checkAd
    Intercept Pharmaceuticals Aktie
    19,000
     
    USD
    0,00 %
    0,000 USD
    Letzter Kurs 08.11.23 NMS
    19,000
     
    USD
    54.200 STK
    Geldkurs 07.11.23
    19,010
     
    USD
    100.300 STK
    Briefkurs 07.11.23
    ISIN: US45845P1084 · WKN: A1J5U0 · SYM: ICPT · USA

    Neueste Nachrichten

    Intercept Announces New PBC Data Analyses to be Presented at Digestive Disease Week 2024 Conference
    09.05.24 · globenewswire · Intercept Pharmaceuticals
    Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva (obeticholic acid) for the Treatment of PBC
    29.02.24 · globenewswire · Intercept Pharmaceuticals
    Intercept Announces New Phase 2 Data Showing Significant Impact of OCA-Bezafibrate Combination on Normalization of Multiple Key Biomarkers of PBC-Induced Liver Damage at AASLD The Liver Meeting 2023
    13.11.23 · globenewswire · Intercept Pharmaceuticals
    Intercept Announces New Findings from Long-term Extension of Landmark POISE Trial in PBC Showing Importance of Biomarkers Beyond ALP at AASLD The Liver Meeting 2023
    10.11.23 · globenewswire · Intercept Pharmaceuticals
    Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.
    08.11.23 · globenewswire · Intercept Pharmaceuticals
    INTERCEPT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intercept Pharmaceuticals, Inc. - ICPT
    16.10.23 · Business Wire (engl.) · Intercept Pharmaceuticals
    INTERCEPT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intercept Pharmaceuticals, Inc. - ICPT
    28.09.23 · Business Wire (engl.) · Intercept Pharmaceuticals
    ICPT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intercept Pharmaceuticals, Inc. Is Fair to Shareholders
    26.09.23 · Business Wire (engl.) · Intercept Pharmaceuticals
    Alfasigma to Acquire Intercept Pharmaceuticals for $19.00 per Share in Cash, Expanding the Global Footprint of Alfasigma Via a Leader in Rare and Serious Liver Diseases
    26.09.23 · globenewswire · Intercept Pharmaceuticals
    Intercept Pharmaceuticals to Conduct Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences
    05.09.23 · globenewswire · Intercept Pharmaceuticals
    E-Autos im Abseits: Bei diesen Aktien rechnen Investoren mit den größten Kursverlusten
    30.08.23 · wallstreetONLINE Redaktion · Intercept Pharmaceuticals
    Intercept Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Updates
    02.08.23 · globenewswire · Intercept Pharmaceuticals